原发性甲状腺淋巴瘤的诊治研究进展  

Advances in the diagnosis and treatment of primary thyroid lymphoma

作　　者：刘婷[1] 齐潇 孙传政[1] Liu Ting;Qi Xiao;Sun Chuanzheng(Department of Head and Neck SurgeryⅡ,the Third Affiliated Hospital of Kunming Medical University,Kunming 650118,China)

机构地区：[1]昆明医科大学第三附属医院头颈外二科,650118

出　　处：《国际耳鼻咽喉头颈外科杂志》2020年第1期29-32,共4页International Journal of Otolaryngology-Head and Neck Surgery

摘　　要：原发性甲状腺淋巴瘤(primary thyroid lymphoma,PTL)是罕见的甲状腺恶性肿瘤,其常见的病理亚型包括弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)和黏膜相关淋巴组织淋巴瘤(mucosa-associated lymphoid tissue lymphoma,MALT),临床很难仅靠细针穿刺细胞学检查和常规组织病理确定其病理亚型,免疫组化和流式细胞仪有助于PTL的诊断.本文就近年来PTL的诊断、治疗和预后研究进展做一综述.Primary thyroid lymphoma(PTL)is a rare malignant tumor,its common pathological subtypes include diffuse large B-cell lymphoma(DLBCL)and mucosa-associated lymphoid tissue lymphoma(MALT).It is difficult to determine the pathological subtypes by fine needle aspirationcytology and routinehistopathology,while the immunohistochemical and flow cytometer can conduce to the diagnosis of PTL.In this paper,the advances in diagnosis,treatment and prognosis of PTL in recent years are reviewed.

关 键 词：甲状腺肿瘤 原发性甲状腺淋巴瘤 

分 类 号：R736.1[医药卫生—肿瘤]